Navigation Links
Bioquark Inc. and Lakmus LLC Announce Research Collaboration to Study Novel Biopharmaceuticals for Healthy Longevity Enhancement
Date:6/30/2017

Bioquark, Inc., (http://www.bioquark.com) a life sciences company focused on the development of novel bio-products for regeneration, disease reversion, and healthy aging, and Moscow based, Lakmus LLC, a diversified investment company with business interests in pharmacies, restaurants, and real estate, announced a multi-disciplinary research collaboration with the FSBI Zakusov Institute of Pharmacology, Russian Academy of Medical Sciences (http://www.academpharm.ru/), and the Pavlov Institute of Physiology of the Russian Academy of Sciences (http://www.infran.ru/), to jointly study the pharmacotherapeutic longevity enhancement properties of its combinatorial regenerative biologic candidates.

“We are very excited about this continued collaboration with Lakmus,” said Ira S. Pastor, CEO, Bioquark Inc. “The disciplined development of our combinatorial biologic candidates (Bioquantines) for healthy longevity enhancement, represents another important step in our continued evolution as a company focused on a broad range of therapeutic products and services in the regenerative healthcare space.”

Throughout the 20th century, natural products formed the basis for a majority of all pharmaceuticals, biologics, and consumer healthcare products used by patients around the globe, generating trillions of dollars of wealth. However, many scientists believe we have only touched the surface with what the natural world, and its range of organisms, which from a health and wellness perspective are much further advanced than human beings, has to teach us.

The integration of a complex set of newer research disciplines, including interkingdom signaling, semiochemical communication, and evolutionary biology, as well as significant recent activity in the areas of the microbiome, are highlighting a myriad of new ways that non-human bio-products can affect the human genome for positive transitions in health and wellness dynamics.

“Bioquark has spent several years studying the natural ability of many species to turn back biological time in order to maintain health, fitness, and survival, developing a broad understanding of the combinatorial biochemical approaches they use to control nested hierarchies of disease (i.e. gene, cell, tissue, organism, environment),” said Dr. Sergei Paylian, Founder, CSO, and President, Bioquark Inc. “This research initiative is one more step in the path in allowing humans to recapture these capabilities to effectively counter our unfortunate progression into aging, disease and degeneration.”

About Bioquark, Inc.

Bioquark Inc. is focused on the development of natural biologic based products, services, and technologies, with the goal of curing a wide range of diseases, as well as effecting complex regeneration. Bioquark is developing both biological pharmaceutical candidates, as well as products for the global consumer health and wellness market segments.

Read the full story at http://www.prweb.com/releases/2017/06/prweb14471477.htm.


'/>"/>
Source: PRWeb
Copyright©2017 Vocus, Inc.
All rights reserved


Related biology technology :

1. Adimarket Named Latin American Distributor for Bioquark Biologic Products for the Regeneration and Repair of Human Organs and Tissue with Stem Cells
2. Bioquark Inc. Announces Approval of Bioquantine Bio-Active Food Additives in Eurasian Customs Union
3. DistinctBright, Probiotic Cleaner, Announces their Probiotic Cleaner is Safe for Pets
4. Annual Conference about Technology Solutions for People with Disabilities Announces Program
5. Probiotic Action Announces Probiotics Lead the Digestive Health Market
6. Verenium Announces Preliminary Financial Results For Fiscal 2012
7. DMG is Proud to Announce that CD Diagnostics will be Featured in an Upcoming Episode of Health Heroes
8. Senomyx Announces Fourth Quarter And Full Year 2012 Financial Results And Initiation Of New Direct Sales Strategy
9. Neuralstem Announces 2012 Financial Results, Provides Clinical Trials Update
10. EAG Announces New General Manager of Release-To-Production (RTP) Division
11. DuPont Tate & Lyle Bio Products Announces Novel Application for Zemea® Propanediol
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/12/2018)... ... September 10, 2018 , ... Franz Inc. , ... technology, AllegroGraph , for Knowledge Graphs, and Semantic Web Company , developers ... today announced a partnership to develop the Noam Chomsky Knowledge Graph. This ...
(Date:9/12/2018)... ... September 12, 2018 , ... NDA Partners Chairman Carl ... Senior Director of Regulatory Affairs and Quality Systems at WellDoc, Inc., has joined ... Affairs and Quality Systems at WellDoc, Inc., she conducted quality control and supplier ...
(Date:9/7/2018)... ... September 06, 2018 , ... ... and commercialization, is releasing the agenda for its upcoming user conference. , ... industries discussing the latest challenges, opportunities, and approaches to regulatory compliance and quality ...
(Date:9/1/2018)... ... August 31, 2018 , ... Rudina Thanasi, a ... a proprietary biofield energy treated nutraceutical supplement used in combating inflammation and autoimmune ... and blood, as well as, organ-specific inflammation. The reported data is as follows: ...
Breaking Biology Technology:
(Date:9/24/2018)... ... September 24, 2018 , ... Energetiq Technology, a world ... announce that starting on October 1, 2018 Hamamatsu will distribute the company’s Laser-Driven ... have been working steadfastly since our acquisition to integrate with Hamamatsu and familiarize ...
(Date:9/22/2018)... ... 2018 , ... Slone Partners, the leading executive search firm ... completion of the Third Annual Life Serve Youth Foundation (LSYF) Tennis Camp. The ... youth. The 60 participants are primarily inner-city teens living in the New York ...
(Date:9/22/2018)... ... September 20, 2018 , ... Global molecular diagnostics company Omixon, ... collaboration to deliver the first integrated epitope determination and matching service that leverages ... the first time, fully characterized HLA sequences and their corresponding 4-field HLA typings ...
Breaking Biology News(10 mins):